Vazquez-Urrutia JR, Venugopal N, Zhu J, Komiya T. Incidence and Prognostic Value of TP53, STK11, and KEAP1 Mutations Between De Novo Versus Recurrent Actionable Mutation–Negative Non-Small Cell Lung Cancer: A Single-Center Retrospective Study. World J Oncol [Internet]. 2026 Jan. 1 [cited 2026 May 9];17(3):310-21. Available from: https://wjon.elmerpub.com/wjon/article/view/2761